For “learningor memory”, lovastatin has been shown to alleviate cognitivedeficits of Noonan syndrome in mice by inhibiting the ERK signalingpathway in the brain (“positive regulation of ERK1 and ERK2cascade” also enriched but not selected by Revigo). The gene discussed is MAPK1; the disease is Noonan syndrome.